Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Myeloproliferative Neoplasms May Be Sensitive to Dual BET/JAK Inhibition

Myeloproliferative Neoplasms May Be Sensitive to Dual BET/JAK Inhibition In myeloproliferative neoplasms (MPN) chromatin changes promote NF-κB signaling to drive inflammation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Discovery American Association of Cancer Research

Myeloproliferative Neoplasms May Be Sensitive to Dual BET/JAK Inhibition

Cancer Discovery , Volume 8 (2): 1 – Feb 1, 2018
Download PDF

Myeloproliferative Neoplasms May Be Sensitive to Dual BET/JAK Inhibition

Cancer Discovery , Volume 8 (2): 1 – Feb 1, 2018

Abstract

In myeloproliferative neoplasms (MPN) chromatin changes promote NF-κB signaling to drive inflammation.

Loading next page...
 
/lp/american-association-of-cancer-research/myeloproliferative-neoplasms-may-be-sensitive-to-dual-bet-jak-FPFVwz3fey

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Association of Cancer Research
Copyright
©2018 American Association for Cancer Research.
ISSN
2159-8274
eISSN
2159-8290
DOI
10.1158/2159-8290.cd-rw2018-002
Publisher site
See Article on Publisher Site

Abstract

In myeloproliferative neoplasms (MPN) chromatin changes promote NF-κB signaling to drive inflammation.

Journal

Cancer Discovery – American Association of Cancer Research

Published: Feb 1, 2018

There are no references for this article.